z-logo
open-access-imgOpen Access
Neither losartan nor atenolol reduce collagen markers beyond blood pressure reduction in hypertension. A LIFE substudy
Author(s) -
Mikkel Christensen,
Michael Hecht Olsen,
Lars Juhl Jensen,
Hans Ibsen
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.477
Subject(s) - medicine , losartan , atenolol , procollagen peptidase , blood pressure , n terminal telopeptide , left ventricular hypertrophy , endocrinology , diastole , cardiology , angiotensin ii , alkaline phosphatase , biochemistry , chemistry , osteocalcin , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom